If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,082.00    -380.00 (-25.99%)
Bid:
1,092.00
Ask:
1,098.00
Spread: 6.00 (0.549%)
Market Cap: £370.45m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Director/PDMR Shareholding

8 Mar 2018 07:00

RNS Number : 0538H
Craneware plc
08 March 2018
 

Craneware plc

("Craneware", "the Group" or the "Company")

 

Director's Exercise of Options

 

8 March 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that Keith Neilson, CEO of the Company, yesterday exercised two tranches of options over a total of 29,081 ordinary shares of 1p each ("Ordinary Shares"). The first tranche of 18,248 Ordinary Shares was exercised at a price of 335 pence per Ordinary Share. The second tranche of 10,833 Ordinary Shares was exercised at a price of 400 pence per Ordinary Share.

 

Following the exercise of these options, Mr Neilson holds 3,377,799 Ordinary Shares in the capital of the Company, representing 12.8% per cent. of the Company's issued share capital.

 

The exercise of options has been fulfilled via the issue of Ordinary Shares held in the Company's Employee Benefit Trust. There is therefore no change to the Company's issued share capital.

 

 For further information, please contact:

 

Craneware plc

Peel Hunt

Alma

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)208 004 4218

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

George Sellar

Hilary Buchanan

Nicole McDougall

Robyn Fisher

 

About Craneware

Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The Company's flagship solution, Chargemaster Toolkit®, has earned the KLAS No.1 ranking in Revenue Cycle - Chargemaster Management since 2006 and is part of Craneware's value cycle management suite, which includes patient engagement, charge capture and pricing, claims analysis, revenue recovery and retention, and cost analytics solutions.

 

Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff.

 

Learn more at www.craneware.com.

 

 

Appendix 1

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name:

Keith Neilson

 

2

Reason for the notification

 

a)

Position/Status:

 

Chief Executive Officer

b)

Initial Notification/Amendment:

 

Initial Notification

3

Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor

 

a)

Name:

Craneware plc

 

b)

LEI:

213800O2CTJ1YFXNXG05

 

4.

Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the financial instrument:

Identification code:

Ordinary Shares

ISIN GB00B2425G68

 

b)

Nature of the transaction:

 

Exercise of Options

 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

£3.35

£4.00

18,248

10,833

d)

Aggregated price(s) and volume(s):

Price(s)

Volume(s)

£3.592

29,081

e)

Date of the Transaction:

 

7 March 2018

f)

Place of the Transaction:

Outside of a trading venue

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAADPEESPEEF
Date   Source Headline
3rd Jul 202612:52 pmRNSPurchase of Shares by Director
3rd Jul 20267:00 amRNSFY26 Trading Update
2nd Jul 20266:07 pmRNSNotification of Major Holdings
15th May 20268:36 amRNSNotification of Major Holdings
13th May 20266:11 pmRNSNotification of Major Holdings
13th May 20261:50 pmRNSNotification of Major Holdings
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20265:11 pmRNSGrant of Share Options to Directors
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
27th Apr 202612:47 pmRNSNotification of Major Holdings
23rd Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSBlock Admission
13th Apr 202610:37 amRNSGrant of Share Option to PDMR
13th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:26 amRNSDividend Currency Election
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
16th Mar 20267:00 amRNSShare buyback programme and Total Voting Rights
4th Mar 20267:00 amRNSDirector's Acquisition of Shares
2nd Mar 20267:00 amRNSFY26 Interim Results
18th Feb 20263:49 pmRNSNotification of Major Holdings
9th Feb 20264:55 pmRNSNotification of Major Holdings
3rd Feb 20263:16 pmRNSNotification of Major Holdings
20th Jan 20267:00 amRNSH1 FY26 Trading Update and Notice of Results
28th Nov 202511:31 amRNSDividend Currency Election
21st Nov 20251:51 pmRNSResult of AGM
21st Nov 20257:00 amRNSAGM Statement and Board Changes
20th Nov 20257:00 amRNSVesting of LTIP Awards and Total Voting Rights
13th Nov 202510:51 amRNSReduction of Capital effective
6th Nov 20253:41 pmRNSReduction of Capital confirmed
22nd Oct 20255:17 pmRNSAnnual Report, Notice of AGM, Directorate Change
22nd Oct 20259:24 amRNSTotal Voting Rights
15th Oct 20257:00 amRNSBlock listing Interim Review
17th Sep 20257:00 amRNSGrant of Long Term Incentive Plan Awards
15th Sep 20257:00 amRNSFY25 Final Results
1st Sep 20257:00 amRNSBank Refinancing
20th Aug 20256:22 pmRNSResult of General Meeting - Replacement
20th Aug 20254:28 pmRNSResult of AGM
1st Aug 20254:35 pmRNSProposed Reduction of Capital
16th Jul 20257:00 amRNSFY25 Trading Update
12th Jun 20253:20 pmRNSForm 8.3 - Craneware plc
12th Jun 202511:55 amRNSForm 8.5 (EPT/RI) - Craneware PLC
11th Jun 20253:00 pmRNSForm 8.3 - Craneware PLC
11th Jun 20252:47 pmRNSForm 8.3 - CRANEWARE PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.